Literature DB >> 24901693

Laparoscopic local excision and rectoanal anastomosis for rectal gastrointestinal stromal tumor: modified laparoscopic intersphincteric resection technique.

Takashi Akiyoshi1, Masashi Ueno, Yosuke Fukunaga, Satoshi Nagayama, Yoshiya Fujimoto, Tsuyoshi Konishi, Hiroya Kuroyanagi.   

Abstract

BACKGROUND: Rectal GI stromal tumor is uncommon. Local excision with free resection margins provides adequate treatment, but extended surgery such as abdominoperineal resection has been frequently performed because of technical difficulties in the confined pelvic space.
OBJECTIVE: We aimed to report the technical details of a new method of local excision for rectal GI stromal tumor: the modified laparoscopic intersphincteric resection technique.
DESIGN: This study was a retrospective analysis.
SETTING: This study was performed at a single institute. PATIENTS: We included 3 patients with rectal GI stromal tumor who underwent this procedure following neoadjuvant imatinib therapy. INTERVENTION: Medial-to-lateral retroperitoneal dissection was begun near the sacral promontory, and rectal dissection while preserving autonomic nerves was performed down to the pelvic floor into the anal canal without dividing the inferior mesenteric artery. Dissection between the tumor and prostate was meticulously performed under laparoscopic magnified view. Next, circumferential connection between the laparoscopic and transanal dissections was performed through a transanal approach, and the rectum was extracted through the anus. Circular full-thickness local excision of the rectum and handsewn straight rectoanal anastomosis was performed. MAIN OUTCOME MEASURES: The safety and feasibility of this procedure were the primary outcomes measured by this study.
RESULTS: The median operative time was 180 minutes, and the median estimated blood loss was 115 mL. There were no conversions or intraoperative complications, and there was 1 postoperative intestinal obstruction that recovered with conservative therapy. All patients had negative resection margins (R0), including 1 pathological complete response. LIMITATIONS: The study was limited by the small number of patients.
CONCLUSIONS: This modified laparoscopic intersphincteric resection technique is a novel and safe method for local excision of rectal GI stromal tumors located very close to the anus (see Video, Supplemental Digital Content 1, http://links.lww.com/DCR/A139).

Entities:  

Mesh:

Year:  2014        PMID: 24901693     DOI: 10.1097/DCR.0000000000000146

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib.

Authors:  Shin Emoto; Takashi Akiyoshi; Toshiki Mukai; Tomohiro Yamaguchi; Toshiya Nagasaki; Tsuyoshi Konishi; Yosuke Fukunaga
Journal:  J Gastrointest Surg       Date:  2021-05-04       Impact factor: 3.452

Review 2.  Management of rectal gastrointestinal stromal tumor.

Authors:  Hitoshi Kameyama; Tatsuo Kanda; Yosuke Tajima; Yoshifumi Shimada; Hiroshi Ichikawa; Takaaki Hanyu; Takashi Ishikawa; Toshifumi Wakai
Journal:  Transl Gastroenterol Hepatol       Date:  2018-02-01

3.  Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.

Authors:  Kennoki Kyo; Masaki Azuma; Kazuya Okamoto; Motohiro Nishiyama; Takahiro Shimamura; Atsushi Maema; Hitoshi Kanamaru; Motoaki Shirakawa; Toshio Nakamura; Kazuya Shinmura; Kenji Koda; Hidetaro Yokoyama
Journal:  World J Surg Oncol       Date:  2016-03-08       Impact factor: 2.754

4.  Different Medical Features and Strategies of Large Rectal Gastrointestinal Stromal Tumor: A Multi-Central Pooling Analysis.

Authors:  Chen Li; Hao Wu; Han Li; Quan Wang; Yang Li; Zhi-Dong Gao; Xiao-Dong Yang; Ying-Jiang Ye; Ke-Wei Jiang
Journal:  Cancer Manag Res       Date:  2021-02-17       Impact factor: 3.989

Review 5.  Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib.

Authors:  Hui Qu; ZhaoHui Xu; YanYing Ren; ZeZhong Gong; Ri Hyok Ju; Fan Zhang; HaoNan Kang; Yang Xu; Xin Chen
Journal:  Cancer Manag Res       Date:  2022-03-16       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.